Find Academic Supervisors

• Medical Oncology
• Urothelial Cancer
• Prostate Cancer
• +7 more

Dr. Debbie Robbrecht is a researcher in the Department of Medical Oncology at Erasmus MC, a leading academic medical center in the Netherlands. Her work is highly focused on translational and clinical oncology, particularly in urothelial and prostate cancers, with a strong emphasis on advanced diagnostics and novel therapeutics. Her research interests span a range of critical areas in modern oncology, including molecular biomarkers , targeted radionuclide therapy , pharmacokinetics/pharmacodynamics , and whole genome sequencing for cancer of unknown primary. She actively investigates how emerging imaging technologies such as PSMA PET/CT influence clinical decision-making and patient management. The recent articles highlight a consistent trend toward integrating precision medicine into oncology practice. Her work frequently involves multidisciplinary collaboration and evaluates real-world applications of cutting-edge therapies, including Lu-PSMA and immunocytokines. The publications reflect deep engagement with clinical trial design, treatment personalization, and biomarker validation across solid tumors. Dr. Robbrecht has no listed scientific awards in the provided text. However, her extensive publication record in high-impact journals suggests significant contributions to the field. She is involved in collaborative research projects, often working with teams across Erasmus MC and external institutions. These collaborations span nuclear medicine, medical oncology, urology, and molecular diagnostics, indicating her role in integrated cancer care research. While no direct information about student supervision or grant funding is available, her position as a co-investigator on multiple clinical studies implies involvement in research mentoring and project leadership. She is associated with advanced oncology research initiatives at Erasmus MC, particularly those involving molecular imaging and targeted therapies. Her work contributes to shaping clinical pathways in prostate and urothelial cancers through evidence generation from real-world data and prospective trials.

• Prostate Cancer
• Urothelial Cancer
• Oncology
• +3 more

Ronald de Wit is a Researcher in the Department of Medical Oncology at Erasmus University Rotterdam with over 300 research outputs spanning prostate cancer, urothelial cancer, and related oncological fields. His primary research focuses include: Castration Resistant Prostate Cancer Prostate Cancer treatments (Docetaxel, Cabazitaxel, Enzalutamide) Immunotherapy applications (Pembrolizumab) Biomarker development for treatment decision-making Pharmacological response monitoring Dr. de Wit's recent publications demonstrate expertise in molecular biomarkers for metastatic urothelial cancer, cell-free DNA analysis in prostate cancer, and risk prediction models for treatment complications. His work bridges translational research with clinical applications, particularly in identifying early response markers and optimizing cancer therapies. His scientific contributions include: Development of novel biomarkers for treatment decision-making Analysis of cell-free DNA as early response markers Post-hoc analyses of immunotherapy efficacy Prediction models for chemotherapy-induced complications Dr. de Wit has supervised 14 students and presented on cancer pain management and patient education, reflecting his commitment to both research and clinical care aspects of oncology.

José Manuel García AznarView profile

Professor

• Computational Mechanics
• Mechanobiology
• Biomedical Engineering
• +3 more

Dr. José Manuel García Aznar is a Full Professor of Structural Mechanics at the Department of Mechanical Engineering, University of Zaragoza. He holds a BSc in Mechanical Engineering and a PhD in Computational Mechanics from the University of Zaragoza, with postdoctoral research conducted at the University of Keele, UK. His research focuses on computational mechanics, mechanobiology, and biomedical engineering, particularly in tumor growth modeling, tissue regeneration, and biomaterials. He leads projects funded by the European Research Council (ERC) and the European Union, including ICoMICS (2022-2026), VAST (2023-2025), and GOALS (2023-2028). His work integrates computational models with experimental data to address challenges in cancer therapy and bone regeneration. Dr. García Aznar has received the Juan C. Simo Young Investigator Award (2004) and serves on editorial boards of journals like Computer Methods in Biomechanics and Biomedical Engineering and Bone . He is also Vice-President of the European Society of Biomechanics (2008-2012) and a member of the Virtual Physiological Human Institute. His research spans tumor-on-chip models, microfluidic devices, and patient-specific simulations, emphasizing the role of mechanical forces in biological processes. Key projects include developing predictive models for tumor growth and fracture risk stratification in cancer patients.

Kevin M BrennanView profile

Associate Professor

• Medical Visualization
• Biomedical Animation
• Molecular Visualization
• +4 more

Kevin M Brennan is an Associate Professor and Program Chair of the Life Sciences and Pre-Medical Illustration Program at Ferris State University. A Certified Medical Illustrator with 15+ years of experience, he specializes in biomedical visualization, animation, and educational technology. His work bridges clinical practice and academic research, focusing on molecular animation, surgical planning in VR, and interactive patient education materials. Before his current role, Brennan served as an Assistant Clinical Professor at the University of Illinois at Chicago’s Biomedical Visualization Program. He has contributed to award-winning projects at Argosy Publishing | Visible Body, including international animations and applications. His research spans diverse topics like digital fossil reconstruction and motion-tracking stroke rehabilitation. Brennan actively contributes to the field through editorial roles at the Journal of Biocommunication and workshops at the Association of Medical Illustrators’ Conference. He mentors in technical direction for special effects (FX TD) and continues creating animations for pharmaceutical, legal, and educational clients. His academic credentials include an M.S. and prior research in invertebrate zoology, radiation effects on cardiac development, and rotifer morphology via SEM. His articles (2017-2019) emphasize innovative visualization techniques in nanomedicine, glycolysis education, and neurocysticercosis modeling.

• Health Economics
• Health Technology Assessment
• Healthcare Economics
• +3 more

Rajan Sharma is a Research Fellow at the Macquarie University Centre for the Health Economy (MUCHE), affiliated with the Macquarie Business School. He holds a PhD in Health Economics from Macquarie University (2016–2019) and has prior experience as a data manager at the Spinal Centre of Southern Denmark and an Instructor in Economic Evaluation at the University of Southern Denmark. His expertise includes economic modeling, health technology assessment, and statistical analysis of healthcare programs using real-world data. Education: PhD in Health Economics (Macquarie University, 2019), MSc in Public Health (Danish State Scholarship recipient, 2012). Research focuses on cost-effectiveness analyses, healthcare policy evaluation, and systematic reviews in areas like prostate cancer diagnostics, cochlear implants, and newborn screening programs. He has presented work at conferences such as the Australian Health Economics Society and Nordic Health Economic Study Group. Awards include the 2022 Macquarie Business School Impact Competition and the International Macquarie University Research Excellence Award for his PhD. He actively participates in academic committees, including the ISPOR Sydney Student and ECR Chapter.

• Prostate Cancer
• Bladder Cancer
• Radiation Therapy
• +3 more

Mette Moe serves as a Senior Physician (Overlæge) at Aalborg University Hospital within the Faculty of Medicine's Department of Oncology. Her research focuses on genitourinary cancers with particular expertise in prostate and bladder cancer treatment modalities. Her primary research interests include: Prostate cancer therapeutics and outcomes Patient-reported outcome measures in oncology Radiation therapy safety and efficacy Chemotherapy regimens for urothelial cancers Molecular imaging applications in cancer management Analysis of her recent publications reveals a strong focus on precision oncology approaches, particularly PSMA-targeted radioligand therapy for prostate cancer as demonstrated in the VISION trial publications. Her work consistently integrates both physician-assessed and patient-reported outcomes, reflecting a patient-centered research approach. The publications span clinical trials methodology, safety analyses, and comparative treatment efficacy studies with emphasis on real-world applications. Moe actively collaborates with multidisciplinary research teams across Denmark and internationally, as evidenced by her co-authorship on major clinical trials. Her work has generated significant academic attention with multiple publications garnering substantial citations and media coverage, including an upcoming media event in August 2025 regarding real-world data on PSMA PET/CT imaging prior to salvage radiotherapy. She contributes to both clinical practice and research within the Department of Oncology, with particular involvement in studies examining treatment-related morbidity and quality of life outcomes for cancer patients undergoing radiation and systemic therapies.

• Surgical Oncology
• Hepatobiliary Surgery
• Cholangiocarcinoma
• +7 more

Stijn Franssen is a researcher in the Department of Surgery at Erasmus MC, a leading academic medical center in the Netherlands. His work is centered on surgical oncology, particularly in the treatment of biliary and liver cancers using advanced interventional techniques such as hepatic arterial infusion (HAIP) therapy. His research interests include cholangiocarcinoma , locoregional cancer therapies , intra-arterial chemotherapy , percutaneous stenting , and perfusion assessment during hepatic surgery. He employs both clinical and imaging-based methodologies to improve patient outcomes, with a focus on survival, technical success, and postoperative complications. His recent publications show a strong trend toward translational and clinical research in hepatobiliary oncology, particularly in refining HAIP therapy and expanding its applications, such as PSMA-targeted delivery. His work frequently involves multicenter collaboration, especially through the Dutch HAIP Consortium, and appears in high-impact surgical and radiological journals. Scientific Contributions and Collaborations: Active contributor to clinical studies on liver resection and risk modeling Key researcher in the development and monitoring of HAIP-based therapies Involved in novel applications of nuclear imaging and targeted drug delivery Collaborates extensively across institutions in the Netherlands Stijn Franssen completed his doctoral thesis in 2024, indicating recent completion of a PhD program. While no formal advising role is mentioned, his involvement in major research projects suggests mentorship within collaborative teams. He has not received any publicly listed scientific awards in the provided data. His research is largely embedded within clinical teams focused on surgical oncology and interventional radiology at Erasmus MC.

• Bone Metastasis
• Vitamin D Signaling
• Osteoblast Biology
• +7 more

Dr. Marjolein van Driel is an Assistant Professor in the Department of Internal Medicine at Erasmus MC, where she conducts cutting-edge research at the intersection of oncology and bone metabolism. Her work primarily focuses on bone metastasis, vitamin D signaling, and tumor-bone microenvironment interactions in cancers such as non-small cell lung cancer and prostate cancer. Her research interests span Bone Metastasis , Vitamin D Signaling , Osteoblast Biology , RANKL Pathway , Extracellular Vesicles , and Cancer-Induced Bone Disease . She investigates how molecular signals from tumors affect bone remodeling and how endocrine factors like vitamin D modulate this crosstalk. The recent trend in her publications shows a strong emphasis on identifying biomarkers for skeletal-related events in lung cancer patients, particularly those with EGFR mutations. Her studies integrate clinical data with molecular analysis to explore RANKL-expressing extracellular vesicles and their potential as non-invasive indicators of bone metastasis progression and treatment response. Dr. van Driel actively collaborates with leading researchers in oncology and bone biology, including Drs. van Leeuwen, Dingemans, and Hendriks. Her collaborative network reflects a multidisciplinary approach combining internal medicine, molecular oncology, and metabolic bone disease research.

• Bioinformatics
• Cancer Genomics
• Molecular Biology
• +3 more

Matti Nykter is a Professor of Bioinformatics at the Faculty of Medicine and Health Technology within the Department of Biomedicine at Tampere University. His research focuses on computational biology, cancer genomics, and systems medicine with an emphasis on prostate cancer, gliomas, and epigenetic mechanisms. Key areas of investigation include: Cancer evolution and therapeutic resistance using liquid biopsy approaches Integration of multi-omics data (genomics, epigenomics, transcriptomics) Bioinformatic methods for analyzing tumor heterogeneity and clonal evolution Zebrafish models for studying host-pathogen interactions His work bridges basic science and clinical applications, developing biomarkers and computational tools for precision oncology. Recent studies explore immunogenomics of cancer, single-cell profiling of tumor microenvironments, and molecular characterization of metastatic progression. Major contributions include: Epigenetic profiling of endocrine-resistant prostate cancer Genomic analysis of Lynch syndrome-associated cancers Development of UCLIB diagnostic panel for non-invasive cancer detection Identification of therapeutic targets via single-cell and spatial transcriptomics

Hege KerstenView profile

Professor

• Geriatric Medicine
• Dementia Research
• Clinical Pharmacology
• +5 more

Hege Kersten is a Professor at the Department of Geriatric Medicine, University of Oslo. Her research spans geriatric medicine, dementia, clinical pharmacology, and public health, with a focus on elderly populations and multimorbidity. Department of Geriatric Medicine, University of Oslo Collaborative research with OUS HF Ullevål Sykehus Her work addresses critical areas such as: Dementia progression and caregiver quality of life Anticholinergic drug burden in elderly patients Impact of polypharmacy and inappropriate prescriptions Psychological distress in prostate cancer survivors Epidemiology of SARS-CoV-2 immunity and multiple sclerosis Key article trends show multidisciplinary efforts in: Longitudinal studies (Alzheimer's, MS) Randomized controlled trials (geriatric assessments) Pharmacogenomic analyses (CYP2D6/2C19) Public health interventions (Norwegian cohorts)

• Bioinformatics
• Computational biology
• Cancer Biology
• +2 more

Davide Bressan serves as a Research Fellow at the Department of Cellular, Computational, and Integrative Biology (CIBIO) at the University of Trento, while also holding a tutoring position with the Department of Sociology and Social Research. His interdisciplinary work bridges computational biology with medical research. Dr. Bressan's research interests span Bioinformatics, Computational Biology, Cancer Biology, RNA Biology, and Molecular Biology. His work demonstrates particular expertise in applying computational approaches to understand disease mechanisms, with emphasis on prostate cancer, neurodegenerative disorders, and genomic instability. He frequently utilizes organoid technology and genomic data analysis in his research. Analysis of his recent publications (2024-2025) reveals a strong focus on molecular mechanisms in cancer and neurodegenerative diseases. His research consistently employs computational and bioinformatics approaches to analyze complex biological systems, with particular attention to transcriptional regulation, genomic instability, and cell lineage specification. Several publications examine the role of specific signaling pathways in disease development and progression. Dr. Bressan actively contributes to academic instruction as a teacher of Scientific Programming, where he focuses on algorithmics with applications in computational biology. His teaching emphasizes practical implementation of algorithms using Python to solve biological problems.

• Technology Management
• Information Systems
• Supply Chain Management
• +3 more

Asoke Dey is an Associate Professor in Management and Health Care at the University of Akron College of Business , where he has served since 2008. His dual expertise spans operations management and healthcare systems , with a focus on information technology integration, supply chain innovation, and quality improvement in clinical settings. Ph.D., University of Minnesota (Operations Management Science) M.B.A., University of Utah (Management) Post Graduate Certificate in General Management, Indian Institute of Management B.S., Bengal Engineering College (Calcutta University) Dr. Dey's research explores healthcare operations through lenses of technology adoption (e.g., RFID, CPOE systems), sustainable logistics , and military-civilian resource pooling . His publications in Journal of Service Research , Health Care Management Science , and Hospital Topics emphasize technology-aided process improvement and data-driven clinical outcomes . Recent work (2022-2015) demonstrates his sustained focus on radiation therapy efficacy in oncology, supply chain sustainability , and collaborative healthcare systems . He has received institutional recognition including the Dean's Teaching Excellence Award (2014) and Service Excellence Award (2022) . As Program Director for the Master of Science in Management (MSM) and chair of multiple faculty committees, Dey contributes to academic governance while maintaining active roles as Editor for the American Journal of Business and reviewer for leading operations journals.

• Applied Machine Learning
• Computer Vision
• Signal Processing
• +7 more

Overview Manfredo Atzori serves as a Scientific Assistant (Adjoint-e scientifique HES A) at HES-SO Valais-Wallis's Haute Ecole de Gestion. His work focuses on advancing machine learning applications in biomedical engineering, digital pathology, and neuroimaging. He leads development of open-source tools like BIDSAlign for EEG standardization and SelfEEG for self-supervised learning in biomedical signals. Research Interests Atzori's research bridges AI and healthcare, emphasizing: Medical Imaging : Histopathology WSI analysis, artifact correction, and cross-modal fusion Prosthetics Control : sEMG-based gesture recognition and adaptive neural interfaces Deep Learning Methodology : Transfer learning optimization, self-supervised pretraining, and reproducibility frameworks Key Contributions 2024 highlights include: Developed RegWSI - winning ACROBAT 2023 challenge for WSI registration Pioneered multimodal WSI-report integration to halve annotation needs Published benchmark studies on Gleason grading deep learning methods Collaborations Active in international projects with institutions like DeeperHistReg group and OpenNeuro. Tools developed are open-source (GitHub: @manfredoatzori) to advance reproducible research practices.

Iskandar RowanView profile

Adjunct Assistant Professor

• Health Decision Science
• Applied Mathematics
• Cost-Effectiveness Analysis
• +7 more

Iskandar Rowan is an Adjunct Assistant Professor of Health Services, Policy, and Practice at Brown University, and the Head/Founder of the Center of Excellence in Decision-Analytic Modeling and Health Economics Research at sitem-insel AG in Bern, Switzerland. He holds a PhD in health services research from the University of Minnesota (2016), specializing in health decision science under Prof. Karen M. Kuntz. His research focuses on applying stochastic differential equations, approximation theory, and statistical decision theory to model disease progression and inform healthcare decisions under uncertainty. He teaches PHP2465A (Introduction to Health Decision Analysis) at Brown and actively collaborates on projects related to Indonesia's healthcare systems. Research interests include cancer screening strategies, cost-effectiveness analysis, mathematical biology, and uncertainty quantification. He emphasizes interdisciplinary approaches bridging applied mathematics and public health, with a focus on decision-making frameworks for resource allocation and policy development. Current affiliations include Brown University and sitem-insel AG. He is based in Providence, RI, and Neuchâtel, Switzerland. Collaborators include Thomas Trikalinos (Director of the Center for Evidence Synthesis in Health) and Issa Dahabreh (Adjunct Associate Professor of Epidemiology).

Christopher P MarquisView profile

Associate Professor

• Bioprocess Engineering
• Protein Biotechnology
• Bioremediation
• +4 more

Christopher P Marquis is an Associate Professor in the School of BABS (Biosciences and Bioengineering) at UNSW Sydney. He holds a PhD in Bioprocess Engineering from the University of Sydney and leads the Recombinant Products Facility (RPF), a core facility specializing in protein production and bioprocess development. His research focuses on protein biotechnology, bioremediation, and bio-nanotechnology interfaces, including projects on organohalide bioremediation, therapeutic bacteriophage production, and recombinant spider silk engineering. Academic Roles: Director of RPF, Convenor of the Biotechnology Program, and course coordinator for BABS3031 Biotechnology and Bioengineering. Research Strengths: Bioprocess optimization, recombinant protein systems, and nanoscale biotechnology applications. Marquis has supervised 3 current PhD and 2 Honours students, contributing to over 89 journal articles and 89+ publications since 1992. His work bridges biochemical engineering with applied biotechnology, emphasizing translational research and industry partnerships through contract services via the RPF.